Results 291 to 300 of about 219,417 (396)

Percentage of free to total PSA as a biomarker of survival in metastatic castration‐resistant prostate cancer

open access: yesBJU International, EarlyView.
Objective To analyse whether the percentage of free to total prostate‐specific antigen (%fPSA) is a prognostic biomarker in metastatic castration‐resistant prostate cancer (mCRPC), as novel studies suggest an elevated %fPSA is associated with adverse oncological outcomes for men with biochemical recurrence of prostate cancer.
Andrew W. Silagy   +13 more
wiley   +1 more source

Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data. [PDF]

open access: yesCancers (Basel)
Fiorica F   +12 more
europepmc   +1 more source

Animal castration

open access: hybrid, 1902
Alexandre François Augustin Liautard
openalex   +2 more sources

Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration‐Resistant Prostate Cancer: PROpel Subset Analysis

open access: yesCancer Science, EarlyView.
In the phase 3 PROpel trial (NCT03732820), first‐line treatment with olaparib plus abiraterone significantly prolonged radiographic progression‐free survival (rPFS) and numerically prolonged overall survival (OS) versus placebo plus abiraterone in patients with metastatic castration‐resistant prostate cancer (mCRPC).
Mototsugu Oya   +20 more
wiley   +1 more source

Fun, flirtation and fear: Selfies in teenage girls digital exchange cultures

open access: yesChildren &Society, EarlyView.
Abstract This paper explores teenage girls' engagement with digital images on social media. Using new feminist materialism, we foreground digital images as an assemblage of materialities (human and more‐than‐human) filled with affective potentials that materialise in/capacities.
Raksha Janak   +2 more
wiley   +1 more source

Cutting‐Edge Advancements in the Antibiotics‐Gut Microbiota‐Urinary Tumour Axis

open access: yesCell Proliferation, EarlyView.
Gut microbiota regulates urological tumors. Antibiotics induce dysbiosis, altering tumor progression/therapy: reducing carcinogen metabolism but impairing immunity. Specific bacteria enhance immune responses and combat endocrine resistance. Future research should unravel microbiota‐cancer links and develop microbiome‐targeted therapies to optimize ...
Jie Wang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy